News Sentiment

CDIO sentiment intelligence

Cardio Diagnostics Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.72 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-6.0% over one week, -13.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

What's Driving Cardio Diagnostics Holdings' Recent Stock Surge

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -6.0% Price reacting lower
Trend fit Trend inactive -13.1% over four weeks
Fair value -89.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 29
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Market source 9
Stock Titan 8
NewMediaWire 6
timothysykes.com 3
The Globe and Mail 2
Business Wire 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 11
Deals and strategy 3
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49
TradingView Direct company coverage

Cardio Diagnostics Holdings (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine

Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing personalized cardiovascular care through AI, epigenetics, and genetic insights. The company aims to make prevention more accessible and actionable, aligning with the broader healthcare shift toward predictive and precision m

Tone
Positive 73/100
Event
Market update
Published
23 Jun 2026 09:40
Source
TradingView
Market source Direct company coverage

Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection

Cardio Diagnostics (CDIO) is utilizing artificial intelligence, genetics, and epigenetics to enhance cardiovascular risk detection and management. The company offers solutions like Epi+Gen CHD(TM), PrecisionCHD(TM), HeartRisk(TM), and CardioInnovate360(TM) to address cardiovascul

Tone
Positive 75/100
Event
Market update
Published
19 Jun 2026 13:09
Source
Market source
NewMediaWire Direct company coverage

Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine

Cardio Diagnostics Holdings (CDIO) focuses on personalized cardiovascular care using AI, epigenetics, and genetic insights to provide predictive and precision medicine. The company aims to make prevention more accessible and scalable, aligning with a broader healthcare industry s

Tone
Positive 91/100
Event
Market update
Published
19 Jun 2026 05:09
Source
NewMediaWire